Annemieke Aartsma-Rus presented on the Dutch Center for RNA Therapeutics at the DIA FDA meeting on oligonucleotides during the session on Individualized Antisense Oligonucleotide Products on April 26. She explained the progress made in the past year and also the collaborations with the 1 mutation 1 medicine consortium and the N-of-1 collaborative.
posted on May 18, 2022
Let us know your questions or suggestions